Please login to the form below

Not currently logged in
Email:
Password:

nab-paclitaxel

This page shows the latest nab-paclitaxel news and features for those working in and with pharma, biotech and healthcare.

Celgene’s Abraxane fails pancreatic cancer trial

Celgene’s Abraxane fails pancreatic cancer trial

Abraxane (nab-paclitaxel) is already approved to treat patients with advanced metastatic pancreatic cancer, but Celgene had been hoping to get approval for the drug as an adjuvant therapy given after

Latest news

More from news
Approximately 3 fully matching, plus 13 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
PRMA Consulting Ltd

PRMA Consulting is an independent consultancy solving some of the most challenging pricing, reimbursement and market access issues facing international...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics